Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Human. Found 770 abstracts

no pagination
Aksoy MO, Kim V, Cornwell WD, Rogers TJ, Kosmider B, Bahmed K, Barrero C, Merali S, Shetty N, Kelsen SG. Secretion of the endoplasmic reticulum stress protein, GRP78, into the BALF is increased in cigarette smokers. Respiratory research. 2017 May 02;18(1):78.   PMCID: PMC5414124
Russo IH, Russo J. Use of human chorionic gonadotropin in the prevention of breast cancer. Women's Health. 2008 Jan;4(1):1-5.
Tiezzi DG, Fernandez SV, Russo J. Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. International Journal of Oncology. 2007 Jan;31(4):823-7.
Cairns PG. Methods for detecting hypermethylated promoters of tumor suppressor genes associated with ovarian cancer using methylation-specific PCR. 2006 Sep 14;:28 pp.
Campbell KS. Genetically modified human natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection. 2006 Jul 08;:90 pp.
Khazak V, Golemis EA, Menon SR, Weber L. Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer. 2006 Feb 02;:49pp.
Lewis-Wambi JS, Jordan VC. Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs). Breast Disease. 2006 Jan;24:93-105.
Maradeo ME, Eldeen MB, Badawi AF. Combinational chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-g. Horizons in Cancer Research. 2006 Jan;36(New Breast Cancer Research):95-109.
Yuan Q, Simmons HH, Robinson MK, Russeva M, Marasco WA, Adams GP. Development of engineered antibodies specific for the Muellerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Molecular Cancer Therapeutics. 2006 Jan;5(8):2096-105.
Yu J, Henske EP. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homolog enriched in brain. Cancer Research. 2006 Jan;66(19):9461-6.
Adams GP, Simmons HH, Yuan Q, Marasco W, Mehta S. Anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer. 2005 Jul 08;:80 pp.
Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano A, Testa JR. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene. 2005 Jan;24(22):3574-82.
Yen TJ, Kao GD. Mitotic checkpoint, aneuploidy and cancer. Advances in Experimental Medicine and Biology. 2005 Jan;570(Genome Instability in Cancer Development):477-99.
Adams GP, Horak EM, Weiner LM, Marks JD. Bispecific scFv antibody molecules capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer. 2004 Apr 04;:57 pp.
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004 Jul 29;23(34):5853-7.
Babb JS, Rogatko A. Bayesian methods for cancer phase I clinical trials. Biostatistics. 2004 Jan;13(Advances in Clinical Trial Biostatistics):1-39.
Borghaei H, Millenson M, Schilder R, Alden M, Rogatko A, Wang H, Padavic-Shaller K, Smith MR. Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma. Cancer (New York, NY, United States). 2004 Jan;101(9):2034-41.
Borghaei H, Schilder RJ. Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin). Seminars in Nuclear Medicine. 2004 Jan;34(1 Suppl 1):4-9.
Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2004 Mar;58(3):743-9.
Cairns P. Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann N Y Acad Sci. 2004 Jun;1022:40-3.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Human

Human Antitumor agents Diagnosis (cancer Neoplasm Mammary gland Phosphorylation Ovary Non-US Gov't Support Carcinoma (ovarian Ovary (carcinoma Prostate gland Radionuclides Molecular cloning Apoptosis Protein sequences Imaging (tumor Bacteriophage Menopause (postmenopause pathology Lung Cosmids Blood plasma Ascitic fluid Simulation and Modeling (Bayesian methods for cancer phase I clin trials) PCR review mitosis aneuploidy cancer tumorigenesis hypermethylation promoter tumor suppressor genes ovarian cancer PCR diagnosis unclassified) Proteins Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (accessory signal unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (antibody conjugated with including toxicity) Transcription factor Smad Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (Smad5 Plasmids Neoplasm Staging unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-Muellerian inhibiting substance type II rt [Radiotherapy] unclassified) neu Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment aspirate Mammary gland (nipple Conformal Radiotherapy paclitaxel and estramustine in patients with non-Hodgkin lymphoma) Signal transduction (inhibitors unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (RIP (ribosome-inactivating protein)-antibody conjugated with Male Human herpesvirus 8 DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (DAP-kinase Sensitivity and Specificity Comparative Study Monoclonal Antibodies Viral vectors (bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (diphtheria-antibody conjugated with fusion products with scFv Salivary gland Adoptive immunotherapy Positron-emission tomography bispecific antibody scFv EGFR family member cancer diagnosis therapy Female Linking agents Protein Kinases Signal transduction (estrogen-induced activation of TSC BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (polyclonal-efficacy assessment Epidermal growth factor receptors Imaging agents Myelotoxicity (paclitaxel and estramustine in patients with non-Hodgkin lymphoma) including toxicity) Transcription factors Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (gene twist-TWIST1 Lama pacos pos feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells) methylation specific PCR ovary cancer diagnosis Sirolimus Urine FcgRII receptors AKT kinase fatty acid synthase ovary carcinoma estrogen tuberin Rheb mTOR kinase pathway breast cancer unclassified) Antibodies and Immunoglobulins Role: BSU (Biological study-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (labeled Combination chemotherapy antibody conjugated with Drug delivery systems (prodrugs Viral vectors Mammary gland (recombinant human chorionic gonadotropin was well tolerated and reduced breast cancer in postmenopausal woman) including toxicity) Transforming growth factor b Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (TGFb1 Lung (toxicity DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (RASSF1A bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer) Keratins Plasmid vectors FceRI receptors pd [Pharmacology] Chemotherapy (antibody conjugated with Blood analysis review breast cancer BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (bispecific scFv antibody Aneuploidy BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (fragments-efficacy assessment aneuploidy and its relationship with tumorigenesis in humans and animals discussed) current knowledge of mitotic checkpoint unclassified) Ribosomal proteins Role: BSU (Biological study-BIOL (Biological study) (S6 Imaging agents (NMR contrast Proto-Oncogene Proteins Drug delivery systems (liposomes unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (TSC2 (tuberous sclerosis complex 2) DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (tumor suppressor of EGFR protein family for diagnosis and treatment of cancer) metabolism Cell death Methylation Tumor markers (methods for detecting hypermethylated promoters of tumor suppressor genes assocd with ovarian cancer using methylation-specific PCR) tu [Therapeutic Use] Testis unclassified) Estrogens Role: BSU (Biological study-BIOL (Biological study) (estrogen-induced activation of TSC Rattus Peroxisome proliferator-activated receptors (g EC 2-7-1-37 (Protein-Serine-Threonine Kinases) Drugs paclitaxel estramustine myelotoxicity nonHodgkin lymphoma review postmenopause breast cancer selective estrogen receptor modulator Chromones carcinoma Uterus (cervix-treatment of Affinity (low and high binding form DGN (Diagnostic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (p14ARF Protein motifs (antigen-binding domain magnetic Spheres (beads-antibody conjugated with Test kits (diagnostic Mustela putorius furo DNA Methylation Gamma ray (emitters Radioimmunotherapy Samples (biol or biopsy Bone marrow including toxicity) Transforming growth factor b Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (TGFb2 FcgRIII receptors MAP Peptide nucleic acids dt [Drug Therapy] Genetic vectors PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv-anti-MISIIR cDNA sequences (genetically modified human natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection) BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (fragments-scFv Epitopes toremifene Mammary gland (tamoxifen-droloxifene-idoxifene-keoxifene and fulvestrant were useful in treatment of postmenopausal estrogen receptor-pos breast cancer patient) Gel electrophoresis (non denaturing recombinant human chorionic gonadotropin was well tolerated and reduced breast cancer in postmenopausal woman) Chemotherapy Equus caballus unclassified) G proteins Role: BSU (Biological study-BIOL (Biological study) (RHEB (Ras homolog enriched in brain) Drug targets Cisplatin FcaRI receptors Fc receptor expressing NK cell therapeutic antibody efficacy assessment Mammary gland (cyclooxygenase-2 inhibitor and peroxisome proliferator-activated receptor-g agonist combination may help in chemoprevention of breast cancer in human) Animal cell Felis Oxidant stress unclassified) Interferons Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (g Carcinoma (mammary ductal Radiation (external beam
Last updated on Wednesday, September 06, 2017